Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Barrett

Showing results (301-310 of 349) with videos related to

Pageof 35
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2016
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic AnemiaKohei Hosokawa, Pawel Muranski, Xingmin Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2010
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionJeffrey S Miller, Edus H Warren, Marcel R M van den Brink, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
Bone Marrow Transplantation|March 9, 2021
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort studyAlexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, et al.
British Journal of Haematology|July 20, 2016
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDSXin Zhao, Xin Tian, Sachiko Kajigaya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2009
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppressionTara N Palmore, Neeral L Shah, Rohit Loomba, et al.
Bone Marrow Transplantation|May 11, 2021
Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort studyAlexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, et al.
Blood|November 25, 2010
T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapyElaine M Sloand, J Joseph Melenhorst, Zachary C G Tucker, et al.
Scientific Reports|February 9, 2018
Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8<sup>+</sup> TCR-Vβ<sup>+</sup> expansionsAnna Lissina, James E McLaren, Mette Ilander, et al.
Pageof 35

Showing results (301-310 of 349) with videos related to

Sort By:
Pageof 35
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2016
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic AnemiaKohei Hosokawa, Pawel Muranski, Xingmin Feng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2010
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionJeffrey S Miller, Edus H Warren, Marcel R M van den Brink, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
Bone Marrow Transplantation|March 9, 2021
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort studyAlexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, et al.
British Journal of Haematology|July 20, 2016
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDSXin Zhao, Xin Tian, Sachiko Kajigaya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 7, 2009
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppressionTara N Palmore, Neeral L Shah, Rohit Loomba, et al.
Bone Marrow Transplantation|May 11, 2021
Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort studyAlexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, et al.
Blood|November 25, 2010
T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapyElaine M Sloand, J Joseph Melenhorst, Zachary C G Tucker, et al.
Scientific Reports|February 9, 2018
Divergent roles for antigenic drive in the aetiology of primary versus dasatinib-associated CD8<sup>+</sup> TCR-Vβ<sup>+</sup> expansionsAnna Lissina, James E McLaren, Mette Ilander, et al.
Pageof 35